Table 6.
Parameters | TAP1 D637G (HPV+/HPV- patients) | OR (95 % CI) | TAP1 I333V (HPV+/HPV- patients) | OR (95 % CI) | ||
---|---|---|---|---|---|---|
AAa | AG/GG | AAa | AG/GG | |||
Tumor depth | ||||||
T1/T2 | 21/16 | 13/35 | 0.283 (0.114–0.703)** | 23/27 | 11/24 | 0.538 (0.218–1.330) |
T3/T4 | 27/9 | 14/15 | 0.311 (0.109–0.888)* | 21/11 | 20/13 | 0.806 (0.294–2.212) |
T1-T4 | 48/25 | 48/25 | 0.281 (0.144–0.551)*** | 44/38 | 31/37 | 0.724 (0.380–1.380) |
“*”represents P < 0.05, “**”indicates P < 0.01, “***”depicts P < 0.001
aReference group. We consider the common homozygotes of TAP1 as ORs of 1.00 for the reference genotype